French IT Stock News

Thinking about what to do with Valneva stock right now? You're not alone. After an eye-catching 111.0% gain so far this year and a robust 31.8% jump over the past month, anyone curious about biotech movers is watching Valneva a bit closer. Seven-day returns are strong too, up 6.5%. However, if you zoom out to three or five years, you’ll see the stock is still deep in the red, trailing by over 20%. That’s quite a ride, which makes any decision more interesting for investors navigating both...

Dassault Aviation société anonyme (ENXTPA:AM) has drawn some attention lately, particularly as investors assess its recent market performance and strong track record. Shares are up 43% year to date, fueling renewed interest in the aerospace group. See our latest analysis for Dassault Aviation société anonyme. The share price momentum for Dassault Aviation société anonyme is hard to ignore, with a robust 43% return year to date as investors respond to the company’s growth outlook and sizeable...

Thinking about what to do with Ipsen stock right now? You are far from alone. After all, Ipsen’s recent moves have left both cautious investors and long-term holders watching closely. Shares have nudged up 2.9% in the past week, even after a slight 2.8% dip over the last month. Year to date, the stock is showing a 3.2% gain, and if you look back over the last three and five years, the growth is even more apparent, with returns of 20.8% and a remarkable 50.8%, respectively. That long-term...

If you are watching Edenred right now and wondering whether this is the moment to buy, hold, or walk away, you are in good company. The recent ups and downs in Edenred's stock have left plenty of investors scratching their heads. On the one hand, the past year has been tough, with the stock dropping by 34.6% and lagging even further behind over the last three years. On the other hand, just this past week, Edenred delivered a bounce of 5.5%, which suggests renewed interest and possibly even an...

If you’re sitting on the fence about Air France-KLM stock, you’re not alone. This stock has certainly kept investors debating their next move. In the past year, shares have soared over 41%, and if you’ve held on since January, you’re up more than 42%, despite recent turbulence with a 12.8% dip in the last thirty days. It’s been a classic case of rapid recoveries and fresh risks, as market sentiment shifts with every new headline in the aviation sector, from evolving travel patterns to oil...

Worldline (ENXTPA:WLN) shares have seen movement recently, and investors are weighing the stock's performance as they look to understand its valuation in today's market. With recent gains this month, the conversation is shifting to prospects ahead. See our latest analysis for Worldline. Worldline's share price has shown only modest changes over the past month, with short-term movements suggesting stabilizing momentum after prior declines. Looking at the bigger picture, the total shareholder...

ABIVAX Société Anonyme (ENXTPA:ABVX) has caught the attention of investors lately as shares have registered modest gains over the past week. The stock’s recent performance may prompt a closer look at its recent business momentum and fundamentals. See our latest analysis for ABIVAX Société Anonyme. Zooming out from last week’s gains, ABIVAX Société Anonyme’s momentum has been quietly building, with a 9.5% share price return over the past 90 days and a 7.3% total shareholder return for the...

If you are thinking about what to do with Derichebourg stock, you are not alone. With so many market voices out there, it can be tough to interpret all the signals, especially after a string of solid performances as seen lately. Derichebourg has just closed at €5.68, and it has notched up a 7.2% gain in the last week alone. In fact, over the last year, shares are up a solid 13.2%, with a truly impressive 149.8% gain over five years. Clearly, this is not simply a fluke or a one-off rally...

Euronext (ENXTPA:ENX) shares have drifted slightly lower over the past week, down nearly 2%, following a more substantial 11% dip over the past month. Investors seem to be weighing recent share price trends in comparison with the company’s broader long-term performance. See our latest analysis for Euronext. Although Euronext’s 1-year total shareholder return has been modest, recent price action suggests investors are recalibrating expectations in light of broader market sentiment and...

In September 2025, the Community of Madrid selected Air Liquide to deliver at-home respiratory care for 70,000 patients under a five-year contract, highlighting the company's operational excellence and innovative digital and AI-powered healthcare solutions. This win not only enhances Air Liquide’s market leadership in Spain but also underscores the growing impact of technology-driven care models in improving patient outcomes and optimizing healthcare costs. We’ll explore how this significant...

Thinking about what to do with your Bureau Veritas stock? You are not alone. With the shares closing at €27.3 recently, investors have been watching a subtle shift in the stock's momentum. Over the past week, Bureau Veritas gained 3.7%, extending a modest 3.4% rise over the last 30 days. While that does not seem earth-shattering, it is a sign that confidence is quietly building after a turbulent start to the year, when the stock slipped 6.1% year-to-date. If you zoom out even further, the...

Airbus (ENXTPA:AIR) shares have seen momentum lately, drawing attention from investors interested in the company’s trajectory. Recent trading activity highlights a steady climb in performance, prompting many to examine what could be fueling the shift. See our latest analysis for Airbus. Airbus shares have steadily edged higher, and the company now trades at €203.55. Momentum has been building, supported by a solid run of annual revenue and net income growth, with the 1-year total shareholder...

If you're eyeing Tikehau Capital and wondering whether now is the moment to make a move, you're not alone. Investors are drawn to the stock after a period of relatively muted action, with the share price up just 0.7% in the last week and over the past month. Despite that, it's still down 8.4% this year and has slipped 15.2% over the past twelve months. Even with a longer lens, the story is mixed: down 12.7% over three years, but up 9.2% over five. That means recent market sentiment toward...

If you're considering adding Forvia to your portfolio, you're not alone. Investors are buzzing about what’s next for the stock. After a challenging stretch in recent years, Forvia has shown clear signs of regaining its footing. Year to date, shares are up a strong 31.1%, and the one-year return stands at 34.3%. Even in the past month alone, the stock has delivered an 8.0% gain, signaling renewed interest and shifting market sentiment around the company’s prospects. Of course, the story isn’t...

If you are thinking about what to do with your Compagnie de Saint-Gobain shares, or wondering whether now is the right time to jump in, you are not alone. With a closing price of 94.32 and steady, sometimes impressive, gains across several time frames, this French building materials giant has caught more than a few eyes lately. Over the last year, the stock is up 18.1%, and looking further back, the 3-year return hits an eye-popping 168.2%, with a 5-year move of 191.7%. Even the short-term...

If you have been watching Valeo, you are probably wondering whether its current stock price of €10.66 represents a smart opportunity or just another stop in a long road of volatility. The stock’s journey has been far from dull. Just look at the numbers: while Valeo gained 3.3% over the past month and is up a solid 13.2% year-to-date, its three- and five-year returns tell a different story, with declines of -25.7% and -56.3% respectively. Over the last week, Valeo slipped by -0.7%, hinting at...

emeis Société anonyme (ENXTPA:EMEIS) shares have caught some attention lately, thanks to changing performance trends. Investors may be exploring what is driving recent moves and how these shifts could influence future sentiment surrounding the stock. See our latest analysis for emeis Société anonyme. With shares currently trading at €14.7, emeis Société anonyme has seen a gentle pickup in momentum, reflected by a year-to-date share price return of 1.4%. However, the one-year total shareholder...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? In a perfect world...

Elis (EPA:ELIS) has had a great run on the share market with its stock up by a significant 6.6% over the last month...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Bonduelle SCA's ( EPA:BON ) recent earnings report didn't offer any surprises, with the shares unchanged over the last...

Danone (ENXTPA:BN) has delivered solid annual financials, with revenue rising 3% and net income up 10% over the past year. This steady growth is drawing attention from investors who are curious about its future valuation path. See our latest analysis for Danone. Danone’s steady operating performance has translated into gentle but positive stock momentum, with its 1-year total shareholder return nudging up 0.18%. After a stretch of relatively stable price action, investors appear to be...

BNP Paribas (ENXTPA:BNP) has seen its stock inch up over the past month, and recent interest in its ongoing financial performance continues to be a talking point among investors who are looking for steady growth in European banking. See our latest analysis for BNP Paribas. BNP Paribas has enjoyed steady momentum, with its share price climbing over the year as investors respond to resilient earnings growth and improving sentiment toward European financials. The bank’s 12-month total...

Argan (ENXTPA:ARG) has seen a small uptick in its share price over the past week, drawing interest from investors curious about recent movements. The company’s stock is up 2% over the past week, adding to its performance this month. See our latest analysis for Argan. Argan’s recent share price gains follow a period of subdued momentum, with the 1-year total shareholder return still in negative territory. While the latest uptick hints at renewed optimism or shifting risk perceptions,...